Catalyst Wire Dossier Catalyst Wire Dossier

Corneal collagen cross-linking (CXL) therapy

· Glaukos Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Corneal collagen cross-linking (CXL) therapy, covering 2021-04-26 to 2021-04-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive Surgery [Phase 3]

See pricing